Actively Recruiting
Database for Interstitial Lung Disease
Led by Medical University of Graz · Updated on 2026-01-15
412
Participants Needed
1
Research Sites
404 weeks
Total Duration
On this page
Sponsors
M
Medical University of Graz
Lead Sponsor
B
Boehringer Ingelheim
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.
CONDITIONS
Official Title
Database for Interstitial Lung Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patients with a known systemic disease that increases the risk for Interstitial Lung Disease (ILD)
- Signed informed consent for participation in the prospective part of the study
You will not qualify if you...
- Age under 18 years
- Having severe health conditions that greatly limit life expectancy, such as serious cardiovascular diseases or malignant cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Graz, Department of Internal Medicine, Division of Pulmonology
Graz, Austria, 8036
Actively Recruiting
Research Team
G
Gabor Kovacs, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here